Results 141 to 150 of about 5,165,706 (279)
Science, technology, and innovation articulation of local public university with economic and social agents [PDF]
Hilda A. Del Carpio Ramos +3 more
openalex +1 more source
A general model for analysis of linear and hyperbolic enzyme inhibition mechanisms
We developed a general enzyme kinetic model that integrates these six basic inhibition mechanism onto a single one. From this model, we deduced a general enzyme kinetic equation that through modulation of simple parameters, γ (the relative inhibitor affinity for two binding sites) and β (the reactivity of the enzyme–substrate–inhibitor complex), is ...
Rafael S. Chagas, Sandro R. Marana
wiley +1 more source
La photographie, une innovation plurielle ?
Amandine Gabriac
doaj +1 more source
Collaborative Innovation for the Management of Information Technology Resources
David O’Sullivan, Lawrence Dooley
openalex +1 more source
Community Masks - from an Emergency Solution to an Innovation Booster for the Textile Industry
Till Batt +12 more
openalex +2 more sources
Thrombolytic proteins profiling: High‐throughput activity, selectivity, and resistance assays
We present optimized biochemical protocols for evaluating thrombolytic proteins, enabling rapid and robust screening of enzymatic activity, inhibition resistance, and fibrin affinity, stimulation, and selectivity. The outcome translates to key clinical indicators such as biological half‐life and bleeding risk. These assays streamline the development of
Martin Toul +3 more
wiley +1 more source
Achieving technological sovereignty implies accelerating innovation and reducing import dependence. An effective tool for addressing these challenges is local content policy (LCP).
Oleg V. Zhdaneev, Ivan R. Ovsyannikov
doaj
Overview of molecular signatures of senescence and associated resources: pros and cons
Cells can enter a stress response state termed cellular senescence that is involved in various diseases and aging. Detecting these cells is challenging due to the lack of universal biomarkers. This review presents the current state of senescence identification, from biomarkers to molecular signatures, compares tools and approaches, and highlights ...
Orestis A. Ntintas +6 more
wiley +1 more source
Driving health transformation: big pharma's innovation labs revolution. [PDF]
Peralta G, Sánchez B.
europepmc +1 more source

